• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体贮积症小鼠模型脑组织中无浸润性外周髓样细胞。

Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders.

机构信息

Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.

Department of Pharmacology, University of Oxford, Oxford, UK.

出版信息

J Neurochem. 2019 Mar;148(5):625-638. doi: 10.1111/jnc.14483. Epub 2018 Aug 9.

DOI:10.1111/jnc.14483
PMID:29900534
Abstract

Approximately 70 lysosomal storage diseases are currently known, resulting from mutations in genes encoding lysosomal enzymes and membrane proteins. Defects in lysosomal enzymes that hydrolyze sphingolipids have been relatively well studied. Gaucher disease is caused by the loss of activity of glucocerebrosidase, leading to accumulation of glucosylceramide. Gaucher disease exhibits a number of subtypes, with types 2 and 3 showing significant neuropathology. Sandhoff disease results from the defective activity of β-hexosaminidase, leading to accumulation of ganglioside GM2. Niemann-Pick type C disease is primarily caused by the loss of activity of the lysosomal membrane protein, NPC1, leading to storage of cholesterol and sphingosine. All three disorders display significant neuropathology, accompanied by neuroinflammation. It is commonly assumed that neuroinflammation is the result of infiltration of monocyte-derived macrophages into the brain; for instance, cells resembling lipid-engorged macrophages ('Gaucher cells') have been observed in the brain of Gaucher disease patients. We now review the evidence that inflammatory macrophages are recruited into the brain in these diseases and then go on to provide some experimental data that, at least in the three mouse models tested, monocyte-derived macrophages do not appear to infiltrate the brain. Resident microglia, which are phenotypically distinct from infiltrating macrophages, are the only myeloid population present in significant numbers within the brain parenchyma in these authentic mouse models, even during the late symptomatic stages of disease when there is substantial neuroinflammation. OPEN SCIENCE BADGES: This article has received a badge for Open Materials because it provided all relevant information to reproduce the study in the manuscript. The complete Open Science Disclosure form for this article can be found at the end of the article. More information about the Open Practices badges can be found at https://cos.io/our-services/open-science-badges/. This article is part of the Special Issue "Lysosomal Storage Disorders".

摘要

目前已知约有 70 种溶酶体贮积症,这些疾病是由于编码溶酶体酶和膜蛋白的基因突变引起的。溶酶体酶水解鞘脂的缺陷已得到相对较好的研究。戈谢病是由于葡萄糖脑苷脂酶活性丧失,导致葡萄糖脑苷脂堆积引起的。戈谢病表现出多种亚型,其中 2 型和 3 型表现出明显的神经病理学。桑德霍夫病是由于β-己糖胺酶活性缺陷,导致神经节苷脂 GM2 堆积引起的。尼曼-匹克 C 型病主要是由于溶酶体膜蛋白 NPC1 的活性丧失,导致胆固醇和神经酰胺的储存。所有这三种疾病都表现出明显的神经病理学,伴有神经炎症。人们通常认为神经炎症是单核细胞衍生的巨噬细胞浸润到大脑的结果;例如,在戈谢病患者的大脑中观察到类似于富含脂质的巨噬细胞('戈谢细胞')的细胞。我们现在回顾了这些疾病中炎症性巨噬细胞被招募到大脑中的证据,然后提供了一些实验数据,至少在我们测试的三种小鼠模型中,单核细胞衍生的巨噬细胞似乎没有浸润大脑。在这些真实的小鼠模型中,只有表型上不同于浸润性巨噬细胞的常驻小胶质细胞,以大量存在于脑实质中,即使在疾病的晚期症状阶段,存在大量神经炎症时也是如此。开放科学徽章:本文获得了“开放材料”徽章,因为它提供了复制本文中研究所需的所有相关信息。本文的完整开放科学披露表格可以在文章末尾找到。有关开放实践徽章的更多信息可以在 https://cos.io/our-services/open-science-badges/ 找到。本文是“溶酶体贮积症特刊”的一部分。

相似文献

1
Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders.溶酶体贮积症小鼠模型脑组织中无浸润性外周髓样细胞。
J Neurochem. 2019 Mar;148(5):625-638. doi: 10.1111/jnc.14483. Epub 2018 Aug 9.
2
Innate immune responses in the brain of sphingolipid lysosomal storage diseases.鞘脂类溶酶体贮积病患者大脑中的先天性免疫反应。
Biol Chem. 2015 Jun;396(6-7):659-67. doi: 10.1515/hsz-2014-0301.
3
Induction of the type I interferon response in neurological forms of Gaucher disease.戈谢病神经学形式中I型干扰素反应的诱导。
J Neuroinflammation. 2016 May 12;13(1):104. doi: 10.1186/s12974-016-0570-2.
4
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.多种溶酶体贮积症内吞途径改变的比较研究
Mol Pharm. 2016 Feb 1;13(2):357-368. doi: 10.1021/acs.molpharmaceut.5b00542. Epub 2016 Jan 11.
5
Mechanism of Secondary Ganglioside and Lipid Accumulation in Lysosomal Disease.溶酶体贮积症中神经节苷脂和脂质蓄积的机制。
Int J Mol Sci. 2020 Apr 7;21(7):2566. doi: 10.3390/ijms21072566.
6
Alterations in membrane trafficking and pathophysiological implications in lysosomal storage disorders.溶酶体贮积症中膜运输的改变及其病理生理学意义
Biochimie. 2016 Nov;130:152-162. doi: 10.1016/j.biochi.2016.09.011. Epub 2016 Sep 21.
7
Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.生物治疗靶点或清除途径:溶酶体贮积病小鼠模型中巨噬细胞甘露糖受体组织分布的分析。
J Inherit Metab Dis. 2011 Jun;34(3):795-809. doi: 10.1007/s10545-011-9285-9. Epub 2011 Mar 17.
8
Ellagic acid and its metabolites urolithins A/B ameliorate most common disease phenotypes in cellular and mouse models for lysosomal storage disorders by enhancing extracellular vesicle secretion.鞣花酸及其代谢物尿石素 A/B 通过增强细胞外囊泡的分泌来改善溶酶体贮积症的细胞和小鼠模型中最常见的疾病表型。
Neurobiol Dis. 2023 Jun 15;182:106141. doi: 10.1016/j.nbd.2023.106141. Epub 2023 Apr 28.
9
Glycoprotein Non-Metastatic Protein B: An Emerging Biomarker for Lysosomal Dysfunction in Macrophages.糖蛋白非转移性蛋白 B:巨噬细胞溶酶体功能障碍的新兴生物标志物。
Int J Mol Sci. 2018 Dec 24;20(1):66. doi: 10.3390/ijms20010066.
10
Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders.C型尼曼-匹克病及其他溶酶体贮积症患者组织中的游离鞘氨醇碱
Biochim Biophys Acta. 1994 May 25;1226(2):138-44. doi: 10.1016/0925-4439(94)90021-3.

引用本文的文献

1
Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.葡萄糖脑苷脂酶缺乏通过细胞免疫激活导致神经病理学。
PLoS Genet. 2024 Nov 11;20(11):e1011105. doi: 10.1371/journal.pgen.1011105. eCollection 2024 Nov.
2
A Comparative Biochemical and Pathological Evaluation of Brain Samples from Knock-In Murine Models of Gaucher Disease.戈谢氏病基因敲入小鼠模型脑组织的比较生化和病理学评估
Int J Mol Sci. 2024 Feb 2;25(3):1827. doi: 10.3390/ijms25031827.
3
Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders.
溶酶体功能障碍的先天免疫感应导致多种溶酶体贮积症。
Nat Cell Biol. 2024 Feb;26(2):219-234. doi: 10.1038/s41556-023-01339-x. Epub 2024 Jan 22.
4
Glucocerebrosidase deficiency leads to neuropathology via cellular immune activation.葡萄糖脑苷脂酶缺乏通过细胞免疫激活导致神经病理学改变。
bioRxiv. 2023 Dec 13:2023.12.13.571406. doi: 10.1101/2023.12.13.571406.
5
Peripheral immune system modulates Purkinje cell degeneration in Niemann-Pick disease type C1.外周免疫系统调节尼曼-匹克病 C1 型的浦肯野细胞变性。
Life Sci Alliance. 2023 Jun 27;6(9). doi: 10.26508/lsa.202201881. Print 2023 Sep.
6
Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy.神经病变型戈谢病中的神经炎症:小胶质细胞和自然杀伤细胞的作用、生物标志物,以及对底物还原治疗的反应。
Elife. 2022 Aug 16;11:e79830. doi: 10.7554/eLife.79830.
7
Gaucher disease: Basic and translational science needs for more complete therapy and management.戈谢病:实现更全面治疗与管理所需的基础与转化科学
Mol Genet Metab. 2021 Feb;132(2):59-75. doi: 10.1016/j.ymgme.2020.12.291. Epub 2020 Dec 29.
8
Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease.鞘脂类代谢途径中的遗传缺陷及其对神经退行性疾病中小胶质细胞的影响。
Cell Signal. 2021 Feb;78:109879. doi: 10.1016/j.cellsig.2020.109879. Epub 2020 Dec 6.
9
Human iPSC-Based Models for the Development of Therapeutics Targeting Neurodegenerative Lysosomal Storage Diseases.基于人类诱导多能干细胞的模型用于开发针对神经退行性溶酶体贮积病的治疗靶点
Front Mol Biosci. 2020 Sep 18;7:224. doi: 10.3389/fmolb.2020.00224. eCollection 2020.
10
Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease.干扰素信号通路缺陷的小鼠有助于区分神经细胞型 Gaucher 病小鼠模型中的原发性和继发性病理途径。
J Neuroinflammation. 2020 Sep 7;17(1):265. doi: 10.1186/s12974-020-01934-x.